Abstract:BACKGROUND: The increase of concentration of plasma homocysteine is the independent risk factor of atherosclerotic and thrombotic cerebral infarction. Genic mutation of methylene tetrahydrofolate reductase (MTHFR), which is the metabolic enzyme of homocysteine in thansulfuration and remethylation, can induce the elevation of the concentration of plasma homocysteine.OBJECTIVE: To explore the relationship of hyperhomocysteinemia and genic mutation of MTHFR of homocysteine with ischemic cerebrovascular disease in youths. DESIGN: Case-control observation.SETTING: Department of Neurology, China-Japan Friendship Hospital, Jilin UniversityPARTICIPANTS: 100 young patients with cerebral infarction, who were hospitalized within 2 days after episode at the Department of Neurology, China-Japan Union Hospital, Jilin University between April 2003 and December 2004, were enrolled as case group, 73 males and 27 females, aged 27-45 years old with an average of (42±5) years. 100 cases in control group were healthy people receiving health examination in the same period, 70 males and 30 females, aged 18-45 years old with an average of (39±4) years.METHODS: The homocysteine in fasting plasma of testees was detected with high performance liquid chromatograpy (HPLC). C677T site and A1298C site of MTHFR gene were analyzed with polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and detected with armplification refractory mutation system (ARMS).MAIN OUTCOME MEASURES: Detection of MTHFR C677T and A1298C gene; Relationship between concentration of plasma homocysteine and MTHFR genotype. RESULTS: A total of 100 inclusive patients and 100 normal control people were involved in the result analysis. ①Detection of MTHFR C677T and A1298C gene: Distribution of genotype, frequency of homozygote and frequency of allele of MTHFR C677T in the case group and control group had significant difference (P < 0.01) while the distribution of genotype, frequency of homozygote and frequency of allele of MTHFR A1298C gene in the case group and control group had insignificant difference (P > 0.05). ②Relationship between the concentration of plasma homocysteine and MTHFR genotype: The concentration of plasma homocysteine between MTHFR C677T and A1298C genotype had significant difference (P < 0.001). The mutant result LSD-t check of the 2 sites showed that mean difference of homozygote and heterozygote, homozygote and concentration of wild type homocysteine had statistical significance (P < 0.05). The mean difference of MTHFR C677T and A1298C heterozygote and concentration of wild type homocysteine in plasma had no statistical significance (P > 0.05). CONCLUSION: The mutation of MTHFR C677T and A1298C leads to the marked increase in the concentration of plasma homocysteine. The MTHFR C677T polymorphism site is the independent risk factor of ischemic cerebrovascular disease in youths. The genic mutation of MTHFR A1298C has no correlation with the attack of ischemic cerebrovascular disease of youths.

[Hyperhomocysteine, Methylenetetrahydrofolate Reductase Gene, and Other Risk Factors in Ischemic Stroke].

The Relationship between Plasma Level of Homocysteine and Polymorphism Distribution of MTHFR Gene in Patients with Ischemic Stroke

The relationship of plasma homocysteine levels and polymorphism in homocysteine metabolism related enzymes with brain stroke

Elevated Plasma Homocysteine Was Associated with Hemorrhagic and Ischemic Stroke, but Methylenetetrahydrofolate Reductase Gene C677T Polymorphism Was a Risk Factor for Thrombotic Stroke

A6282 Association of Homocysteine with Aysmptomatic Intracranial and Extracranial Arterial Stenosis in Hypertension Patients

Association Between 5,10-Methylenetetrahydrofolate Reductase C677T Gene Polymorphism and Risk of Ischemic Stroke: A Meta-analysis.

Polymorphism of the methylenetetrahydrofolate reductase gene association with homocysteine and ischemic stroke in type 2 diabetes.

Association of Homocysteine with Aysmptomatic Intracranial and Extracranial Arterial Stenosis in Hypertension Patients

Single nucleotide polymorphism of MTHFR rs1801133 associated with elevated Hcy levels affects susceptibility to cerebral small vessel disease

Methylenetetrahydrofolate Reductase C677t Polymorphism, Hypertension And Risk Of Stroke: A Prospective, Nested Case-Control Study

Homocysteine and Stroke Risk

Association between MTHFR C677T Gene Polymorphisms and the Efficacy of Vitamin Therapy in lowering Homocysteine Levels among Stroke Patients with Hyperhomocysteinemia

Methylenetetrahydrofolate Reductase C677T Polymorphism, Hypertension, and Risks of Stroke: A Prospective Nested Case–control Study

Relationship between independent risk factor of ischemic cerebrovascular disease in youth and genic mutation of methylene tetrahydrofolate reductase

Abstract MP13: Plasma Homocysteine is Causally Associated With Ischemic Stroke in a Han Chinese Population: A Mendelian Randomization Study

Relationship Between the Gene Polymorphism of MTHFR and the Cerebral Thrombosis

Hyperhomocysteinemia and Methylenetetrahydrofolate Reductase Polymorphism in Cervical Artery Dissection: A Meta-Analysis

Relationship Between Polymorphism of Methylenetetrahydrofolate Reductase Gene and Plasma Homocysteine Level with Intracranial Aneurysm

High Plasma Homocysteine Levels Contribute to the Risk of Stroke Recurrence and All-Cause Mortality in a Large Prospective Stroke Population.

A Mendelian Randomization Study of Plasma Homocysteine and Ischemic Stroke in a Han Chinese Population.

The U-Shaped Relationship Between Serum Methylene Tetrahydrofolate Reductase And Large-Artery Atherosclerotic Stroke